S&P Equity Research Downgrades Medicis Pharmaceutical (MRX) to Strong Sell
Tweet Send to a Friend
S&P Equity Research downgrades Medicis Pharmaceutical (NYSE: MRX) from Hold to Strong Sell.
S&P analyst, H. Saftlas, says ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
S&P analyst, H. Saftlas, says ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
